Thornfeldt R E, Franklin R W, Pickering N A, Thornfeldt C R, Amell G
Am J Obstet Gynecol. 1978 May 15;131(2):143-8. doi: 10.1016/0002-9378(78)90656-7.
The effect of glucocorticoid on the maturation of premature lung membranes was studied in 121 premature infants by administering variable dosages of Decadron to the 114 mothers prior to delivery. The results were compared with findings in a group of 390 infants born in the same hospital during this study. Administration of all three test doses, 8, 16, and 24 mg., significantly decreased the incidence of RDS in all gestational age and birth weight categories. For infants less than 32 weeks, the incidence was decreased from 75 to 46.2%; those 32 to 36 weeks, from 58 to 20.2%; and in those older than 36 weeks, from 24.4 to 0 per cent. The incidence in infants less than 1,000 grams was reduced from 100 to 71.5%; 1,000 to 1,500 grams, from 67.4 to 21.6%; 1,500 to 2,000 grams, from 52.3 to 22.6%; and in heavier than 2,000 grams, from 38.1 to 13.4%. The results also showed that glucocorticoid does not significantly reduce RDS if administered less than 24 hours prior to delivery. The incidence is reduced more than 50% if administered more than 24 hours prior to delivery.
通过在分娩前给114名母亲使用不同剂量的地塞米松,对121名早产儿进行了糖皮质激素对早产肺膜成熟影响的研究。将结果与该研究期间在同一家医院出生的390名婴儿的研究结果进行了比较。所有三种测试剂量8毫克、16毫克和24毫克的给药,均显著降低了所有孕周和出生体重类别的呼吸窘迫综合征(RDS)发病率。对于孕周小于32周的婴儿,发病率从75%降至46.2%;对于孕周为32至36周的婴儿,发病率从58%降至20.2%;对于孕周大于36周的婴儿,发病率从24.4%降至0%。体重小于1000克的婴儿发病率从100%降至71.5%;体重在1000至1500克之间的婴儿,发病率从67.4%降至21.6%;体重在1500至2000克之间的婴儿,发病率从52.3%降至22.6%;体重超过2000克的婴儿,发病率从38.1%降至13.4%。结果还表明,如果在分娩前不到24小时给药,糖皮质激素不会显著降低RDS发病率。如果在分娩前超过24小时给药,发病率降低超过50%。